Episode notes
Hepatocellular carcinoma is a major health problem worldwide, being the fifth most common cancer and the third among cancer-related deaths. Surgery represents the cornerstone treatment for early stages, and Minimally Invasive Liver Surgery (MILS) has become an attractive option thanks to reduced intraoperative blood losses, shortened length of hospital stay, and similar oncological outcomes when compared to open liver resection. Nonetheless, the safety of MILS is still debated in challenging situations, such as in cirrhotic patients, difficult tumor locations, multiple or large tumors, and repeat resection.
In this podcast, Prof. Ho-Seong Han, professor of Surgery at Seoul National University College of Medicine, and renewed world leader in laparoscopic liver resection, discusses with his fellow Dr. Gianluca Cassese ...
... Read more